These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22925670)

  • 1. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. 1984.
    Glenner GG; Wong CW
    Biochem Biophys Res Commun; 2012 Aug; 425(3):534-9. PubMed ID: 22925670
    [No Abstract]   [Full Text] [Related]  

  • 2. Farewell, 'renegade researcher': your voice will be missed.
    Smith GC
    J Neurochem; 2012 Jan; 120 Suppl 1():1-2. PubMed ID: 22150467
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.
    Glenner GG; Wong CW
    Biochem Biophys Res Commun; 1984 May; 120(3):885-90. PubMed ID: 6375662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of a beta-amyloid precursor sequence by cathepsin D.
    Austen BM; Stephens DJ
    Biomed Pept Proteins Nucleic Acids; 1995; 1(4):243-6. PubMed ID: 9346839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amyloid precursor protein and Alzheimer's disease].
    Chen SD; Fang JJ
    Sheng Li Ke Xue Jin Zhan; 1993 Oct; 24(4):306-9. PubMed ID: 8202682
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of the high affinity heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II).
    Multhaup G; Mechler H; Masters CL
    J Mol Recognit; 1995; 8(4):247-57. PubMed ID: 8588942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal heterogenicity of amyloid protein examined in Alzheimer's disease.
    Pirim I; Erdogan AR; Tan U
    Int J Neurosci; 2004 Jan; 114(1):75-81. PubMed ID: 14660069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolism of Alzheimer's amyloid precursor protein].
    Takeda S; Watanabe T; Suzuki T
    Tanpakushitsu Kakusan Koso; 1997 Aug; 42(11):1859-65. PubMed ID: 9279120
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease.
    Selkoe DJ
    Annu Rev Cell Biol; 1994; 10():373-403. PubMed ID: 7888181
    [No Abstract]   [Full Text] [Related]  

  • 10. A two decade contribution of molecular cell biology to the centennial of Alzheimer's disease: are we progressing toward therapy?
    Dillen K; Annaert W
    Int Rev Cytol; 2006; 254():215-300. PubMed ID: 17148000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets are the primary source of amyloid beta-peptide in human blood.
    Chen M; Inestrosa NC; Ross GS; Fernandez HL
    Biochem Biophys Res Commun; 1995 Aug; 213(1):96-103. PubMed ID: 7639768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid precursor protein (APP) and beta A4 amyloid in Alzheimer's disease and Down syndrome.
    Beyreuther K; Dyrks T; Hilbich C; Mönning U; König G; Multhaup G; Pollwein P; Masters CL
    Prog Clin Biol Res; 1992; 379():159-82. PubMed ID: 1409743
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.
    Seubert P; Vigo-Pelfrey C; Esch F; Lee M; Dovey H; Davis D; Sinha S; Schlossmacher M; Whaley J; Swindlehurst C
    Nature; 1992 Sep; 359(6393):325-7. PubMed ID: 1406936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks beta/A4 amyloid immunoreactivity.
    Kametani F; Tanaka K; Ishii T; Ikeda S; Kennedy HE; Allsop D
    Biochem Biophys Res Commun; 1993 Mar; 191(2):392-8. PubMed ID: 8460999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimer's disease.
    Peacock ML; Murman DL; Sima AA; Warren JT; Roses AD; Fink JK
    Ann Neurol; 1994 Apr; 35(4):432-8. PubMed ID: 8154870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.
    Tanzi RE; McClatchey AI; Lamperti ED; Villa-Komaroff L; Gusella JF; Neve RL
    Nature; 1988 Feb; 331(6156):528-30. PubMed ID: 2893290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aβ42 and Aβ40: similarities and differences.
    Qiu T; Liu Q; Chen YX; Zhao YF; Li YM
    J Pept Sci; 2015 Jul; 21(7):522-9. PubMed ID: 26018760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abnormal proteins in the brain in Alzheimer's disease].
    Kanemaru K; Ihara Y
    Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):2-11. PubMed ID: 1900947
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid and efficient screening of Alzheimer's disease β-amyloid inhibitors using label-free gold nanoparticles.
    Geng J; Qu K; Ren J; Qu X
    Mol Biosyst; 2010 Dec; 6(12):2389-91. PubMed ID: 20931124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development.
    Kerr ML; Small DH
    J Neurosci Res; 2005 Apr; 80(2):151-9. PubMed ID: 15672415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.